CO NECTAR Trademark
Trademark Overview
On Thursday, December 19, 2024, a trademark application was filed for CO NECTAR with the United States Patent and Trademark Office. The USPTO has given the CO NECTAR trademark a serial number of 98911999. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 15, 2025. This trademark is owned by HoneyBear Biosciences, Inc.. The CO NECTAR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; medicines for human purposes, namely, medicinal preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; pharmaceutical preparations for prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; chemical preparations for medical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; biological preparations for medical purposes for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; immunostimulants; radioactive substances for ...
Chemical research; chemical analysis; research and development services in the field of chemistry; biological research; bacteriological research; scientific research in the nature of conducting clinical trials for others; medical research; scientific research in the field of genetics; consulting services in the field of pharmaceutical research and development; research and development of new products for third parties in the scientific and medical field; research and development of new products for others; technological research in the field of pharmaceutical studies; conducting scientific study and research in the fields of medicine, prevention, treatment and management of illness, health care delivery, disease detection and treatment; technical writing; scientific laboratory services; scientific research; technological consultancy in the field of pharmaceuticals; culturing of cells for others for scientific research purposes; laboratory services for biomanufacturing.
General Information
| Serial Number | 98911999 |
| Word Mark | CO NECTAR |
| Filing Date | Thursday, December 19, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, July 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 15, 2025 |
Trademark Statements
| Description of Mark | The mark consists of the stylized wording "CO" and "NECTAR" where the letter "O" comprises a circular shape at the center and two additional circular shapes stem off of it extending to the right. Between the letters "O" and "N" are two stacked square shapes. |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; medicines for human purposes, namely, medicinal preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; pharmaceutical preparations for prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; chemical preparations for medical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; biological preparations for medical purposes for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; immunostimulants; radioactive substances for medical purposes; chemico-pharmaceutical preparations; vaccines; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; chemical preparations for pharmaceutical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Chemical research; chemical analysis; research and development services in the field of chemistry; biological research; bacteriological research; scientific research in the nature of conducting clinical trials for others; medical research; scientific research in the field of genetics; consulting services in the field of pharmaceutical research and development; research and development of new products for third parties in the scientific and medical field; research and development of new products for others; technological research in the field of pharmaceutical studies; conducting scientific study and research in the fields of medicine, prevention, treatment and management of illness, health care delivery, disease detection and treatment; technical writing; scientific laboratory services; scientific research; technological consultancy in the field of pharmaceuticals; culturing of cells for others for scientific research purposes; laboratory services for biomanufacturing. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 19, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 19, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | HoneyBear Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 115021
TW |
| Party Name | HoneyBear Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Taipei City 115021
TW |
Trademark Events
| Event Date | Event Description |
| Thursday, December 19, 2024 | NEW APPLICATION ENTERED |
| Wednesday, May 28, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, May 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 5, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, June 11, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, June 11, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 11, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 11, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 11, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 15, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 15, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
